MKI67 and neoplasm: Finally, the authors conducted an in vivo experiment using xenograft models of BxPC-3, showing an inhibition of tumor growth through the deregulation of the FGFR/RAS/ERK pathway and a negative regulation of Ki67 expression, a proliferation marker [25].